ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentSchlierenRedbiotec AG
Redbiotec AG Logo
Verified· 3 sources

Redbiotec AG

Summary

About the company

The core activity of Redbiotec AG is the development and production of key proteins and genetic materials for the biopharmaceutical and food industries. The company focuses on the research and development of therapeutic bacteria for the treatment of cancer and genetic diseases.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered5
Key proteins and genetic materials
Key proteins and genetic materials for biopharma and food industry, including protein expression and cell-free manufacturing of DNA products such as pDNA and mRNA templates.
Casein proteins
Engineering yeast and bacteria to produce casein proteins for animal-free milk and other dairy products, including kappa casein expression and scale-up development.
Cell-free manufacturing of genetic materials
Cell-free manufacturing of genetic materials such as pDNA and templates for mRNA manufacturing, with fast and cost-efficient DNA product production and microfluidics collaboration.
Therapeutic vaccine development
Development of vaccines to fight difficult diseases, including therapeutic vaccine programs based on preclinical research and immunotherapy approaches.
HSV-2 therapeutic vaccine program
HSV-2 therapeutic vaccine development with T-cell-mediated protection, preclinical efficacy data and a two-injection immunotherapy approach.
Press

Media

June 20, 2017Media
Gewinner des Venture-Wettbewerbs stehen fest
netzwoche.ch

Knowledge

No knowledge articles yet

Once Redbiotec AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Redbiotec AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Redbiotec AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Redbiotec AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Wagistrasse 23
8952 Schlieren

At a glance

Legal form
Corporation
UID
CHE-113.257.804
Founded
2006 · 20 years
Last commercial register change
January 18, 2024
Employees
11 to 20

Similar companies

ST
Stiftung Technopark Zürich
Zurich
SO
SwissDrones Operating AG
Zurich
AH
A. Heim GmbH
Fehraltorf
SC
Stem Cell Bank of Switzerland GmbH
Zurich